Abstract
Removal of highly abundant proteins in plasma is often carried out using immunoaffinity depletion to extend the dynamic range of measurements to lower abundance species. While commercial depletion columns are available for this purpose, they generally are not applicable to limited sample quantities (<20 μL) due to low yields stemming from losses caused by nonspecific binding to the column matrix and concentration of large eluent volumes. Additionally, the cost of the depletion media can be prohibitive for larger-scale studies. Modern LC-MS instrumentation provides the sensitivity necessary to scale-down depletion methods with minimal sacrifice to proteome coverage, which makes smaller volume depletion columns desirable for maximizing sample recovery when samples are limited, as well as for reducing the expense of large-scale studies. We characterized the performance of a 346 μL column volume microscale depletion system, using four different flow rates to determine the most effective depletion conditions for ∼6-μL injections of human plasma proteins and then evaluated depletion reproducibility at the optimum flow rate condition. Depletion of plasma using a commercial 10-mL depletion column served as the control. Results showed depletion efficiency of the microscale column increased as flow rate decreased, and that our microdepletion was reproducible. In an initial application, a 600-μL sample of human cerebrospinal fluid (CSF) pooled from multiple sclerosis patients was depleted and then analyzed using reversed phase liquid chromatography-mass spectrometry to demonstrate the utility of the system for this important biofluid where sample quantities are more commonly limited.
Similar content being viewed by others
References
Pang JX, Ginanni N, Dongre AR, Hefta SA, Opitek GJ (2002) J Proteome Res 1:161–169
Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT (2008) Clin Cancer Res 14:6246–6252
Jacobs JM, Adkins JN, Qian WJ, Liu T, Shen Y, Camp DG 2nd, Smith RD (2005) J Proteome Res 4:1073–1085
Kroksveen AC, Opsahl JA, Aye TT, Ulvik RJ, Berven FS (2011) J Proteome 74:371–388
Hu S, Loo JA, Wong DT (2006) Proteomics 6:6326–6353
Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, Qi X, Cao Y, Su M, Wang X, Xu LX, Yen Y, Liu P, Jia W (2011) Mol Cell Proteomics 10(M110):004945
Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, Lonigro RJ, Tsodikov A, Wei JT, Tomlins SA, Chinnaiyan AM (2008) Cancer Res 68:645–649
Shen Y, Moore RJ, Zhao R, Blonder J, Auberry DL, Masselon C, Pasa-Tolić L, Hixson KK, Auberry KJ, Smith RD (2003) Anal Chem 75:3596–3605
Ahmed N, Rice GE (2005) J Chromatogr B Anal Technol Biomed Life Sci 815:39–50
Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD (2003) Mol Cell Proteomics 2:1096–1103
Shores KS, Knapp DR (2007) J Proteome Res 6:3739–3751
Polaskova V, Kapur A, Khan A, Molloy MP, Baker MS (2010) Electrophoresis 31:471–482
Yuan X, Desiderio DM (2005) Proteomics 5:541–550
Boschetti E, Righetti PG (2008) J Proteome 71:255–264
Ly L, Wasinger VC (2011) Proteomics 11:513–534
Gong Y, Li X, Yang B, Ying W, Li D, Zhang Y, Dai S, Cai Y, Wang J, He F, Qian X (2006) J Proteome Res 5:1379–1387
Liu T, Qian WJ, Gritsenko MA, Camp DG 2nd, Monroe ME, Moore RJ, Smith RD (2005) J Proteome Res 4:2070–2080
Rifai N, Gillette MA, Carr SA (2006) Nat Biotechnol 24:971–983
Pernemalm M, Lewensohn R, Lehtiö J (2009) Proteomics 9:1420–1427
Fang X, Huang L, Feitelson JS, Zhang WW (2004) Drug Discov Today Technol I:141–148
Zolotarjova N, Martosella J, Nicol G, Bailey J, Boyes BE, Barrett WC (2005) Proteomics 5:3304–3313
Huang L, Harvie G, Feitelson JS, Gramatikoff K, Herold DA, Allen DL, Amunngama R, Hagler RA, Pisano MR, Zhang WW, Fang X (2005) Proteomics 5:3314–3328
Zhou M, Lucas DA, Chan KC, Issaq HJ, Petricoin EF III, Liotta LA, Veenstra TD, Conrads TP (2004) Electrophoresis 25:1289–1298
Gundry RL, Fu Q, Jelinek CA, Van Eyk JE, Cotter RJ (2007) Proteomics Clin Appl 1:73–88
Yocum AK, Yu K, Oe T, Blair IA (2005) J Proteome Res 4:1722–1731
Qian WJ, Kaleta DT, Petritis BO, Jiang H, Liu T, Zhang X, Mottaz HM, Varnum SM, Camp DG 2nd, Huang L, Fang X, Zhang WW, Smith RD (2008) Mol Cell Proteomics 7:1963–1973
Bandow JE (2010) Proteomics 10:1416–1425
Wetterhall M, Zuberovic A, Hanrieder J, Bergquist J (2010) J Chromatogr B Anal Technol Biomed Life Sci 878:1519–1530
Liu T, Qian WJ, Mottaz HM, Gritsenko MA, Angela DN, Moore RJ, Purvine SO, Camp DG 2nd, Smith RD (2006) Mol Cell Proteomics 5:2167–2174
Corrigan L, Jefferies C, Clive LT, Daly J (2011) Proteomics 11:3415–3419
Seam N, Gonzales DA, Kern SJ, Hortin GL, Hoehn GT, Suffredini AF (2007) Clin Chem 53:1915–1920
Schutzer SE, Liu T, Natelson BH, Angel TE, Schepmoes AA, Purvine SO, Hixson KK, Lipton MS, Camp DG, Coyle PK, Smith RD, Bergquist J (2010) PLoS One 5:e10980
Dujmovic I (2011) Mult Scler Int 2011:767083
Brown JN, Ortiz GM, Angel TE, Jacobs JM, Gritsenko M, Chan EY, Purdy DE, Murnane RD, Larsen K, Palermo RE, Shukla AK, Clauss TR, Katze MG, McCune JM, Smith RD (2012) Mol Cell Proteomics 11:605–618
Brown RN, Romine MF, Schepmoes AA, Smith RD, Lipton MS (2010) J Proteome Res 9:4454–4463
Cao L, Bryant DA, Schepmoes AA, Vogl K, Smith RD, Lipton MS, Callister SJ (2012) Photosynth Res 110:153–168
Kim S, Gupta N, Pevzner PA (2008) J Proteome Res 7:3354–3363
Piehowski PD, Petyuk VA, Sandoval JD, Burnum KE, Kiebel GR, Monroe ME, Anderson GA, Camp DG 2nd, Smith RD (2013) Proteomics 13:766–770
Liu H, Sadygov RG, Yates JR 3rd (2004) Anal Chem 76:4193–4201
Shuford CM, Hawkridge AM, Burnett JC Jr, Muddiman DC (2010) Anal Chem 82:10179–10185
Borg J, Campos A, Diema C, Omeñaca N, de Oliveira E, Guinovart J, Vilaseca M (2011) Clin Proteomics 8:6
Tu C, Rudnick PA, Martinez MY, Cheek KL, Stein SE, Slebos RJ, Liebler DC (2010) J Proteome Res 9:4982–4991
Yue G, Luo Q, Zhang J, Wu SL, Karger BL (2007) Anal Chem 79:938–946
Qian WJ, Liu T, Petyuk VA, Gritsenko MA, Petritis BO, Polpitiya AD, Kaushal A, Xiao W, Finnerty CC, Jeschke MG, Jaitly N, Monroe ME, Moore RJ, Moldawer LL, Davis RW, Tompkins RG, Herndon DN, Camp DG, Smith RD (2009) J Proteome Res 8:290–299
Liebler DC, Ham AJ (2009) Nat Methods 6:785, author reply 785–786
Ogata Y, Charlesworth MC, Higgins L, Keegan BM, Vernino S, Muddiman DC (2007) Proteomics 7:3726–3734
Stoop MP, Rosenling T, Attali A, Meesters RJ, Stingl C, Dekker LJ, van Aken H, Suidgeest E, Hintzen RQ, Tuinstra T, van Gool A, Luider TM, Bischoff RM (2012) J Proteome Res 11:4315–4325
Slysz GW, Lewis DF, Schriemer DC (2006) J Proteome Res 5:1959–1966
Massolini G, Calleri E (2005) J Sep Sci 28:7–21
Zougman A, Pilch B, Podtelejnikov A, Kiehntopf M, Schnabel C, Kumar C, Mann M (2008) J Proteome Res 7:386–399
Mouton-Barbosa E, Roux-Dalvai F, Bouyssié D, Berger F, Schmidt E, Righetti PG, Guerrier L, Boschetti E, Burlet-Schiltz O, Monsarrat B, Gonzalez de Peredo A (2010) Mol Cell Proteomics 9:1006–1021
Pan S, Zhu D, Quinn JF, Peskind ER, Montine TJ, Lin B, Goodlett DR, Taylor G, Eng J, Zhang J (2007) Proteomics 7:469–473
Bora A, Anderson C, Bachani M, Nath A, Cotter RJ (2012) J Proteome Res 11:3143–3149
Cunningham R, Jany P, Messing A, Li L (2013) J Proteome Res 12:719–728
Acknowledgments
This project was supported by grants from the National Center for Research Resources (5 P41 RR018522-10) and the National Institute of General Medical Sciences (8 P41 GM103493-10) from the National Institutes of Health as well as the Department of Energy Office of Biological and Environmental Research Genome Sciences Program under the Pan-omics project. Work was performed in the Environmental Molecular Science Laboratory, a U.S. Department of Energy (DOE) national scientific user facility at Pacific Northwest National Laboratory (PNNL) in Richland, WA. Battelle operates PNNL for the DOE under contract DE-AC05-76RLO01830. We appreciate the favor from Jonas Bergquist at Uppsala University (Department of Chemistry-Biomedical Center, Analytical Chemistry and SciLife Lab, Uppsala, Sweden) for the donation of CSF sample.
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Hyung, SW., Piehowski, P.D., Moore, R.J. et al. Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid. Anal Bioanal Chem 406, 7117–7125 (2014). https://doi.org/10.1007/s00216-014-8058-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-014-8058-3